CBA-China 2026: Meet Datwyler at Booth #D60
Elastomer Expertise for GLP-1 Injectables and Container Closure Innovation at China's Premier Biologics Event
Where GLP-1 Packaging Challenges Meet Elastomer Innovation
CBA-China brings together China's leading biologics manufacturers, CDMOs, pharmaceutical developers, and packaging specialists — and Datwyler will be there to engage with the teams at the forefront of the country's rapidly expanding GLP-1 and injectable drug market.
About our talk
David Qiu, Key Account Manager at Datwyler, takes the stage to present on:
- The technical challenges of elastomer components for GLP-1 injectable drug packaging
- The demands factors like material science, compatibility, and performance place on primary packaging systems
Want to connect?
Find us at Booth #60, where attendees can connect with Datwyler's regional and global experts to explore our comprehensive portfolio of:
- Container closure systems
- NeoFlex™ and OmniFlex® elastomer platforms
- Drug delivery components
All engineered to meet the quality, regulatory, and scalability demands of China's domestic and export-focused pharmaceutical industry.
Presentation Details
Technical Challenges in the Elastomer Components for Drug Packaging of GLP-1 Injectables
Meet the Speakers
What We're Showcasing at Chinese Biopharmaceutical Association - China
Explore the solutions and technologies most relevant to this event.
Presentation: Technical Challenges in Elastomer Components for GLP-1 Injectable Drug Packaging
NeoFlex™ & OmniFlex® Platforms for GLP-1 and Biologic Drug Delivery
Pharmaceutical Packaging Solutions for China's Growing Market
Continue Exploring
Access additional materials and information related to this event and Datwyler’s solutions.